CTRI/2023/07/054853尚未招募3 期
To evaluate the skin irritation and sensitization potential of the 6 Investigational products by repeated application of occlusive patches - Not Applicable
Skinovate Laser & Cosmetic Surgery center0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Healthy male and female volunteers aged 18 to 65 with no active dermatological conditions
- •2.Good general and mental health with, in the opinion of the investigator or medically qualified designee with no clinically significant and relevant abnormalities in medical history or upon physical examination
- •3.Subjects who have intact skin on the proposed application site; dorsum (scapular region)
- •4.Fitzpatrick photo type I to IV skin type
- •5.Willingness to participate as evidenced by voluntary written informed consent
排除标准
- •1.Women who are known to be pregnant or who are intending to become pregnant over the duration of the study
- •2.Women who are breast-feeding
- •3.Any history of significant dermatological diseases or conditions or medical conditions known to alter skin appearance or physiologic response (e.g. diabetes,) which could, in the opinion of the Investigator, preclude topical application of the investigational products and/or interfere with the evaluation of the test site reaction.
- •4.Presence of open sores, pimples, or cysts at the application site.
- •5.Active dermatosis (local or disseminated) that might interfere with the results of the study.
- •6.Considered immune compromised.
- •7.History of diseases aggravated or triggered by ultraviolet radiation.
- •8.Participants with dermatographism.
- •9.Currently using any medication which in the opinion of the investigator, may affect the evaluation of the study product, or place the subject at undue risk.
- •10.Use of the following topical or systemic medications: immunosuppressants, antihistamines, nonhormonal anti-inflammatory drugs, and corticosteroids up to 2 weeks before screening visit.
- •11.Oral or topical treatment with vitamin A acid and/or its derivatives up to 1 month before the screening visit
- •12.Intention of being vaccinated during the study period or vaccination within 3 weeks of the screening visit.
- •13.Currently receiving allergy injections, or due to receive an injection within 7 days prior to Visit1, or expects to begin injections during study participation
- •14.Previous history of atop, allergic reactions, irritation or intense discomfort feelings to topical use products, cosmetics, or medication
- •15.Known or suspected intolerance or hypersensitivity to any of the study
- •materials (or closely related compounds) or any of their stated ingredient including any component of the patches
- •16.History of sensitization in a previous patch study
- •17.Participation in another clinical study (including cosmetic studies) or receipt of an investigational drug within 30days of the screening visit
- •18.Recent history (within the last years) of alcohol or other substance abuse
研究者
相似试验
尚未招募
不适用
To Assess the irritation potential of face wash, Sunscreen and night cream, by repeat application of patches on human skin.CTRI/2021/07/034854SKINOVATE LASER COSMETIC SURGERY CENTRE
尚未招募
Unknown
To study the irritant and allergic potential of test products in Men and Women.CTRI/2024/07/070626Dr. Reddys Laboratories Ltd.,
尚未招募
Unknown
To study the irritant and allergic potential of a test product in Men and Women.CTRI/2024/02/062234Dr. Reddys Laboratories Ltd
已完成
不适用
To Assess the skin irritation potential of face wash, Sunscreen and night cream, by repeated application of patches on human skin.CTRI/2021/07/034826Mr Amol Khedkar
已完成
不适用
To check is the test product is causing irritation or allergy in men/women after repeated applications of patch.CTRI/2021/04/033208yka Labs Limited219